论文部分内容阅读
2013年6月26日,国家食品药品监督管理总局为在2015年年底前完成新修订药品GSP的实施工作,就有关事项印发通知。通知精神如下:(1)贯彻实施新修订药品GSP,是规范药品流通秩序,提高药品经营管理和服务水平,维护公众健康权益的重要措施。各级食品药品监管部门务必推进工作有序开展。(2)新修订药品GSP的实施是推动职能转变的良好契机,职能转变的要求也为顺利实施新修订药品GSP提供了有力的支持。做好两项行政许可行为的整合工作。从现在
On June 26, 2013, the State Food and Drug Administration will complete the implementation of the newly revised drug GSP by the end of 2015 and issue a notice on relevant issues. The spirit of the notice is as follows: (1) Implementing the newly revised GSP is an important measure to standardize the circulation of pharmaceutical products, improve the management and service level of pharmaceutical products and safeguard public health rights and interests. Food and drug regulatory authorities at all levels must promote the work in an orderly manner. (2) The implementation of the newly revised drug GSP is a good opportunity to promote the transformation of the functions. The requirements of the functional changes also provide strong support for the smooth implementation of the newly revised GSP. Do a good job in the integration of two administrative licensing activities. from now on